| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1440-1827.2001.01186.X |
| P698 | PubMed publication ID | 11328534 |
| P2093 | author name string | Horiguchi H | |
| Hirose T | |||
| Sano T | |||
| P2860 | cites work | A genetic model for colorectal tumorigenesis | Q27860582 |
| Mutations in the p53 gene occur in diverse human tumour types | Q28249770 | ||
| Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas | Q28269089 | ||
| Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours | Q29618396 | ||
| Clonal expansion of p53 mutant cells is associated with brain tumour progression | Q34233614 | ||
| Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples | Q38482210 | ||
| Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis | Q38484197 | ||
| A tiger behind many doors: multiple genetic pathways to malignant glioma | Q40372189 | ||
| A molecular genetic model of astrocytoma histopathology | Q40898740 | ||
| Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas | Q46026796 | ||
| Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells | Q48105086 | ||
| A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme | Q48260047 | ||
| Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors | Q48277581 | ||
| Subsets of glioblastoma multiforme defined by molecular genetic analysis | Q48379049 | ||
| Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression | Q48671489 | ||
| Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value | Q48823367 | ||
| Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas | Q48972634 | ||
| Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. | Q55477826 | ||
| Detection of structural aberrations of chromosome 17 in malignant gliomas by fluorescence in situ hybridization (FISH). | Q55481332 | ||
| Prognostic implications of p53 overexpression in supratentorial astrocytic tumors. | Q55481635 | ||
| P4510 | describes a project that uses | fluorescence in situ hybridization | Q1336182 |
| P433 | issue | 3 | |
| P304 | page(s) | 187-192 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Pathology International | Q15758750 |
| P1476 | title | TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization | |
| P478 | volume | 51 |
| Q39913695 | Engineering of clinical glioma treatment: prediction of pro-invasive molecular events in treated gliomas |
| Q38601004 | Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil. |
Search more.